Skip to main content
Clinical Trials/ChiCTR2100047137
ChiCTR2100047137RecruitingUnknown

催产素敏感性和母婴结局的相关性研究

Not provided1 site in 1 country1,750 target enrollmentStarted: June 7, 2021Last updated:

Trial Snapshot

Phase
Unknown
Status
Recruiting
Enrollment
1,750
Locations
1
Primary Endpoint
Apgar 评分

Study Overview

Brief Summary

探讨催产素敏感性和母婴结局的相关性。

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to — (—)
Sex
All

Inclusion Criteria

  • 1.正常单胎妊娠(孕周>=28 周)
  • 2.阴道分娩、无子宫收缩、催产素输注引产。

Exclusion Criteria

  • 3.已知对催产素治疗过敏;
  • 4.胎儿畸形,胎儿窘迫,骨盆狭窄,前置胎盘,脐带脱垂,横位;
  • 5.既往有子宫破裂史。

Arms & Interventions

催产素敏感组

催产素不敏感组

Outcomes

Primary Outcomes

Apgar 评分

脐血 pH

产后出血

转儿科

Secondary Outcomes

  • 第一产程
  • 第二产程
  • 第三产程
  • 产钳助产

Investigators

Study Sites (1)

Loading locations...

Similar Trials